Signal Peptide Database - Viruses

 Entry Details
ID   3829
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   A3EXG6    (Created: 2007-06-12 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name   SPIKE_BCHK9
Protein Name   Spike glycoprotein
Gene   S
Organism Scientific   Bat coronavirus HKU9
Organism Common   BtCoV
Lineage   Viruses
  ssRNA positive-strand viruses, no DNA stage
    Nidovirales
      Coronaviridae
        Coronavirus
          Coronavirus group 2
            Coronavirus group 2d
Protein Length [aa]   1274
Protein Mass [Da]   139717
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   14
chain   Spike glycoprotein   potential   15   1274
chain   Spike protein S1   potential   15   676
chain   Spike protein S2   potential   677   1274
transmembrane region      potential   1213   1233
topological domain   Extracellular   potential   15   1212
topological domain   Cytoplasmic   potential   1234   1274
glycosylation site   N-linked (GlcNAc...)   potential   30   30
glycosylation site   N-linked (GlcNAc...)   potential   34   34
glycosylation site   N-linked (GlcNAc...)   potential   90   90
glycosylation site   N-linked (GlcNAc...)   potential   154   154
glycosylation site   N-linked (GlcNAc...)   potential   165   165
glycosylation site   N-linked (GlcNAc...)   potential   199   199
glycosylation site   N-linked (GlcNAc...)   potential   205   205
glycosylation site   N-linked (GlcNAc...)   potential   304   304
glycosylation site   N-linked (GlcNAc...)   potential   423   423
glycosylation site   N-linked (GlcNAc...)   potential   459   459
glycosylation site   N-linked (GlcNAc...)   potential   521   521
glycosylation site   N-linked (GlcNAc...)   potential   547   547
glycosylation site   N-linked (GlcNAc...)   potential   572   572
glycosylation site   N-linked (GlcNAc...)   potential   644   644
glycosylation site   N-linked (GlcNAc...)   potential   663   663
glycosylation site   N-linked (GlcNAc...)   potential   688   688
glycosylation site   N-linked (GlcNAc...)   potential   705   705
glycosylation site   N-linked (GlcNAc...)   potential   791   791
glycosylation site   N-linked (GlcNAc...)   potential   1042   1042
glycosylation site   N-linked (GlcNAc...)   potential   1081   1081
glycosylation site   N-linked (GlcNAc...)   potential   1096   1096
glycosylation site   N-linked (GlcNAc...)   potential   1113   1113
glycosylation site   N-linked (GlcNAc...)   potential   1128   1128
glycosylation site   N-linked (GlcNAc...)   potential   1133   1133
glycosylation site   N-linked (GlcNAc...)   potential   1157   1157
glycosylation site   N-linked (GlcNAc...)   potential   1163   1163
glycosylation site   N-linked (GlcNAc...)   potential   1172   1172
glycosylation site   N-linked (GlcNAc...)   potential   1193   1193
site   Cleavage   potential   676   677
compositionally biased region   Cys-rich      1235   1253
short sequence motif   Di-lysine motif   by similarity   1270   1274
SP Length   14
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MLLILVLGVSLAAA
Sequence MLLILVLGVSLAAASRPECFNPRFTLTPLNHTLNYTSIKAKVSNVLLPDP
YIAYSGQTLRQNLFMADMSNTILYPVTPPANGANGGFIY
NTSIIPVSAGL
FVNTWMYRQPASSRAYCQEPFGVAFGDTFENDRIAILIMAPDNLGSWSAV
APR
NQTNIYLLVCSNATLCINPGFNRWGPAGSFIAPDALVDHSNSCFVNN
TFSV
NISTSRISLAFLFKDGDLLIYHSGWLPTSNFEHGFSRGSHPMTYFM
SLPVGGNLPRAQFFQSIVRSNAIDKGDGMCTNFDVNLHVAHLINRDLLVS
YFN
NGSVANAADCADSAAEELYCVTGSFDPPTGVYPLSRYRAQVAGFVRV
TQRGSYCTPPYSVLQDPPQPVVWRRYMLYDCVFDFTVVVDSLPTHQLQCY
GVSPRRLASMCYGSVTLDVMRI
NETHLNNLFNRVPDTFSLYNYALPDNFY
GCLHAFYL
NSTAPYAVANRFPIKPGGRQSNSAFIDTVINAAHYSPFSYVY
GLAVITLKPAAGSKLVCPVA
NDTVVITDRCVQYNLYGYTGTGVLSKNTSL
VIPDGKVFTASSTGTIIGVSI
NSTTYSIMPCVTVPVSVGYHPNFERALLF
NGLSCSQRSRAVTEPVSVLWSASATAQDAFDTPSGCVVNVELR
NTTIVNT
CAMPIGNSLCFI
NGSIATANADSLPRLQLVNYDPLYDNSTATPMTPVYWV
KVPT
NFTLSATEEYIQTTAPKITIDCARYLCGDSSRCLNVLLHYGTFCND
INKALSRVSTILDSALLSLVKELSINTRDEVTTFSFDGDY
NFTGLMGCLG
PNCGATTYRSAFSDLLYDKVRITDPGFMQSYQKCIDSQWGGSIRDLLCTQ
TYNGIAVLPPIVSPAMQALYTSLLVGAVASSGYTFGITSAGVIPFATQLQ
FRLNGIGVTTQVLVENQKLIASSFNNALVNIQKGFTETSIALSKMQDVIN
QHAAQLHTLVVQLGNSFGAISSSINEIFSRLEGLAANAEVDRLINGRMMV
LNTYVTQLLIQASEAKAQNALAAQKISECVKAQSLRNDFCG
NGTHVLSIP
QLAPNGVLFIHYAYTPTEYAFVQTSAGLCH
NGTGYAPRQGMFVLPNNTNM
WHFTTMQFYNPV
NISASNTQVLTSCSVNYTSVNYTVLEPSVPGDYDFQKE
FDKFYK
NLSTIFNNTFNPNDFNFSTVDVTAQIKSLHDVVNQLNQSFIDLK
KLNVYEKTIKWP
WYVWLAMIAGIVGLVLAVIMLMCMTNCCSCFKGMCDCR
RCC
GSYDSYDDVYPAVRVNKKRTV
Original MLLILVLGVSLAAASRPECFNPRFTLTPLNHTLNYTSIKAKVSNVLLPDP
YIAYSGQTLRQNLFMADMSNTILYPVTPPANGANGGFIYNTSIIPVSAGL
FVNTWMYRQPASSRAYCQEPFGVAFGDTFENDRIAILIMAPDNLGSWSAV
APRNQTNIYLLVCSNATLCINPGFNRWGPAGSFIAPDALVDHSNSCFVNN
TFSVNISTSRISLAFLFKDGDLLIYHSGWLPTSNFEHGFSRGSHPMTYFM
SLPVGGNLPRAQFFQSIVRSNAIDKGDGMCTNFDVNLHVAHLINRDLLVS
YFNNGSVANAADCADSAAEELYCVTGSFDPPTGVYPLSRYRAQVAGFVRV
TQRGSYCTPPYSVLQDPPQPVVWRRYMLYDCVFDFTVVVDSLPTHQLQCY
GVSPRRLASMCYGSVTLDVMRINETHLNNLFNRVPDTFSLYNYALPDNFY
GCLHAFYLNSTAPYAVANRFPIKPGGRQSNSAFIDTVINAAHYSPFSYVY
GLAVITLKPAAGSKLVCPVANDTVVITDRCVQYNLYGYTGTGVLSKNTSL
VIPDGKVFTASSTGTIIGVSINSTTYSIMPCVTVPVSVGYHPNFERALLF
NGLSCSQRSRAVTEPVSVLWSASATAQDAFDTPSGCVVNVELRNTTIVNT
CAMPIGNSLCFINGSIATANADSLPRLQLVNYDPLYDNSTATPMTPVYWV
KVPTNFTLSATEEYIQTTAPKITIDCARYLCGDSSRCLNVLLHYGTFCND
INKALSRVSTILDSALLSLVKELSINTRDEVTTFSFDGDYNFTGLMGCLG
PNCGATTYRSAFSDLLYDKVRITDPGFMQSYQKCIDSQWGGSIRDLLCTQ
TYNGIAVLPPIVSPAMQALYTSLLVGAVASSGYTFGITSAGVIPFATQLQ
FRLNGIGVTTQVLVENQKLIASSFNNALVNIQKGFTETSIALSKMQDVIN
QHAAQLHTLVVQLGNSFGAISSSINEIFSRLEGLAANAEVDRLINGRMMV
LNTYVTQLLIQASEAKAQNALAAQKISECVKAQSLRNDFCGNGTHVLSIP
QLAPNGVLFIHYAYTPTEYAFVQTSAGLCHNGTGYAPRQGMFVLPNNTNM
WHFTTMQFYNPVNISASNTQVLTSCSVNYTSVNYTVLEPSVPGDYDFQKE
FDKFYKNLSTIFNNTFNPNDFNFSTVDVTAQIKSLHDVVNQLNQSFIDLK
KLNVYEKTIKWPWYVWLAMIAGIVGLVLAVIMLMCMTNCCSCFKGMCDCR
RCCGSYDSYDDVYPAVRVNKKRTV
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11